Gastroenterology Research and Practice

Research Article

Fatty Liver Index and Lipid Accumulation Product Can Predict Metabolic Syndrome in Subjects without Fatty Liver Disease

Table 4

Characteristics of subjects with IFG.


	IFG	Non-IFG	P value
	()	( 22,970)	P value

BMI,			<0.001
Age,			<0.001
Sex (M/F) (%)	3036/1965	11,859/11,111	<0.001
Sex (M/F) (%)	(60.7/39.3)	(51.6/48.4)	<0.001
WC,			<0.001
SBP,			<0.001
DBP,			<0.001
Fasting glucose, mg/			<0.001
Cholesterol, mg/			<0.001
HDL, mg/			<0.001
LDL, mg/			<0.001
TG, mg/			<0.001
AST, IU/			<0.001
ALT, IU/			<0.001
GGT, IU/			<0.001
Platelet,			<0.001
Fatty liver (yes/no) (%)		8737/14,233	<0.001
	(63.0/37.0)	(38.0/62.0)	<0.001
FLI			<0.001
LAP			<0.001

as mean standard deviation.
IFG, impaired fasting glucose; BMI, body mass index; M, male; F, female; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triglyceride; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma-glutamyl transferase; LAP, lipid accumulation product.